mRNA-0184

DRUG3 trials

Sponsors

ModernaTX, Inc.

Conditions

Chronic Heart FailureHealthy Participants

Phase 1

A Study to Evaluate the Safety of mRNA-0184 in Participants With Heart Failure

CompletedNCT05659264

ModernaTX, Inc.Chronic Heart Failure

Start: 2022-12-05End: 2024-12-17Updated: 2025-03-17

Study to Investigate Safety and Tolerability of mRNA-0184 Administered Under Different Infusion Conditions in Healthy Participants

CompletedNCT06243770

ModernaTX, Inc.Healthy Participants

Start: 2024-02-16End: 2025-06-12Updated: 2025-08-01

A Study to Investigate Safety and Tolerability of mRNA-0184 Administered Subcutaneously in Healthy Participants

RecruitingNCT06655870

ModernaTX, Inc.Healthy Participants

Start: 2024-10-31End: 2026-12-16Target: 42Updated: 2026-09-15